• Dr.Marella Manasa
• Dr.Yerikala Ramesh

Background :Orthopedic infections are challenging and require effective antimicrobial therapies. New strategies are required due to the emergence of multidrug-resistant strains. Developing innovative medicines, controlling infections, comprehending microbial resistance, and using antibiotics sensibly are all important tactics. Microbiota in orthopedic infections: Gram-positive bacteria, particularly Staphylococcus aureus and coagulase-negative staphylococci (CoNS), are the primary causes of orthopedic infections. S.aureus is notorious for its virulence, antibiotic resistance, and biofilm-forming abilities. Orthopedic infections are also caused by other organisms, such as Cutibacterium acnes, Enterococcus, and Streptococcus. PJIs are increasingly being caused by gram-negative bacteria such Pseudomonas aeruginosa and Escherichia coli. Effective therapy is severely hampered by the emergence of antibiotic-resistant strains, such as MRSA, VRSA, and carbapenem-resistant enterobacteria. Developing focused antimicrobial tactics requires an understanding of the range of infections and their resistance patterns. Tailoring Antimicrobial Therapy for Orthopedic Infections: Treatment with antibiotics for orthopedic infections should be customized according to patient risk factors, pathogen sensitivity, and culture findings. To lower surgical site infections (SSIs), screening and decontamination procedures for S. aureus are important factors to take into account. In order to avoid SSIs, antibiotic prophylaxis—usually with cefazolin—is essential. Beta-lactam antibiotics, rifampicin, glycopeptides, and fluoroquinolones—which target specific pathogens—are among the available therapy choices. Antibiotics like daptomycin and rifampicin are efficient against bacteria buried in biofilms, thus controlling biofilms is also crucial. Targeted treatment is provided by local antimicrobial administration, such as spacers and bone cements filled with gentamicin. Effective treatment requires an understanding of pharmacokinetics and pharmacodynamics, and combination therapy and targeted delivery can assist treat complicated infections and lower germ resistance. Conclusions: Antimicrobials are crucial for preventing and treating orthopedic infections. however, resistance poses a significant global challenge. A multifaceted approach is needed, including prudent antibiotic use, stringent infection control measures, and robust stewardship programs. Ongoing research and global collaboration are essential to address this growing threat and preserve the effectiveness of antibiotics.

Orthopedic infections, Microbiota, Microbial resistance, Antibiotics.

"CLINICAL OVERVIEW OF ORTHOPEDIC INFECTIONS AND THE GROWING THREAT OF ANTIMICROBIAL RESISTANCE-A SCHEMATIC REVIEW", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.12, Issue 11, page no.e800-e804, November-2025, Available :http://www.jetir.org/papers/JETIR2511501.pdf

"CLINICAL OVERVIEW OF ORTHOPEDIC INFECTIONS AND THE GROWING THREAT OF ANTIMICROBIAL RESISTANCE-A SCHEMATIC REVIEW", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.12, Issue 11, page no. ppe800-e804, November-2025, Available at : http://www.jetir.org/papers/JETIR2511501.pdf